- There is no such thing as a clear proof but on the transmissibility or immune evasion
- The variant continues to develop quickly as a variant of concern globally
- “There may be inadequate information,” INSACOG stated
There is no such thing as a clear proof but on the transmissibility, immune evasion or severity of Omicron in India, stated Indian SARS-CoV-2 Genomics Consortium (INSACOG) in its newest bulletin whereas noting that the variant continues to develop quickly as a variant of concern globally.
The bulletin, dated December 13 and revealed on Monday, stated public well being measures and investigations are being performed to look into the brand new variant.
“Presently, there isn’t any clear proof relating to transmissibility, immune evasion, or severity in India,” INSACOG stated.
It additional stated that whereas the Delta variant, together with its B.1.617.2 (AY) and AY.x sublineages, continues to be the principle variant of concern globally, Omicron continues to develop quickly.
“Circumstances have continued to extend in South Africa, with a smaller however clear rise in hospitalizations. Pending full genomic sequencing, within the UK, S-gene goal failure has proven a really fast improve in possible Omicron instances and this could symbolize a major development benefit in opposition to Delta,” the INSACOG stated.
The consortium stated that whereas there are some indicators that the illness could also be milder with Omicron, there’s inadequate information to find out whether or not that is due to prior infections or vaccination.
“There may be inadequate information for Omicron severity in unvaccinated or partially vaccinated older topics,” INSACOG stated.
(Apart from the headline, this story has not been edited by IHNS workers and is revealed from a syndicated feed.)